P. A. Borea, S. Gessi, S. Merighi, F. Vincenzi, and K. Varani, Pharmacology of adenosine receptors: The state of the art, Physiol. Rev, vol.98, pp.1591-1625, 2018.

G. Burnstock, Purinergic Signaling in the Cardiovascular System, Circ. Res, vol.120, pp.207-228, 2017.

A. Bahreyni, A. Avan, M. Shabani, M. Ryzhikov, H. Fiuji et al., Therapeutic potential of A2 adenosine receptor pharmacological regulators in the treatment of cardiovascular diseases, recent progress, and prospective, J. Cell Physiol, vol.234, pp.1295-1299, 2019.

M. Peleli, B. B. Fredholm, L. Sobrevia, and M. Carlström, Pharmacological targeting of adenosine receptor signaling, Mol. Aspects Med, vol.55, pp.4-8, 2017.

K. A. Jacobson, D. K. Tosh, S. Jain, and Z. G. Gao, Historical and current adenosine receptor agonists in preclinical and clinical development, Front. Cell Neurosci, vol.13, 2019.

R. P. Stephenson, A modification of receptor theory, Br. J. Pharmacol, vol.120, pp.106-120, 1956.

J. L. Bowser, J. W. Lee, X. Yuan, and H. K. Eltzschig, The hypoxia-adenosine link during inflammation, J. Appl. Physiol, vol.123, pp.1303-1320, 2017.

J. Linden, G. J. Harrison, R. J. Willis, and J. P. Headrick, Adenosine in tissue protection and tissue regeneration, Mol. Pharmacol, vol.67, pp.1385-1387, 2005.

N. J. Wright and S. Y. Lee, Structures of human ENT1 in complex with adenosine reuptake inhibitors, Nat. Struct. Mol. Biol, vol.26, pp.599-606, 2019.

B. Ullman, L. J. Gudas, A. Cohen, D. W. Martin, and . Jr, Deoxyadenosine metabolism and cytotoxicity in cultured mouse T lymphoma cells: A model for immunodeficiency disease, Cell, vol.14, pp.365-375, 1978.

L. Belardinelli, J. C. Shryock, Y. Song, D. Wang, and M. Srinivas, Ionic basis of the electrophysiological actions of adenosine on cardiomyocytes, FASEB J, vol.9, pp.359-365, 1995.

T. J. Park, S. Chung, M. K. Han, U. H. Kim, and K. T. Kim, Inhibition of voltage-sensitive calcium channels by the A2A adenosine receptor in PC12 cells, J. Neurochem, vol.71, pp.1251-1260, 1998.

M. Brugarolas, G. Navarro, E. Martínez-pinilla, E. Angelats, V. Casadó et al., G-protein-coupled receptor heteromers as key players in the molecular architecture of the central nervous system, CNS Neurosci. Ther, vol.20, pp.703-709, 2014.

F. Ciruela and E. Sotelo, Special Issue: Adenosine receptors, vol.22, 2017.

L. Singh, R. Kulshrestha, N. Singh, and A. S. Jaggi, Mechanisms involved in adenosine pharmacological preconditioning-induced cardioprotection, Korean J. Physiol. Pharmacol, vol.22, pp.225-234, 2018.

, Int. J. Mol. Sci, vol.20, p.5964, 2019.

F. Paganelli, A. Saadjian, J. J. Sampol, J. Maixent, S. Levy et al., Effects of percutaneous transluminal coronary angioplasty on coronary adenosine concentrations in humans, Eur. J. Clin. Invest, vol.30, pp.105-110, 2000.

J. C. Deharo, M. Brignole, and R. Guieu, Adenosine hypersensitivity and atrioventricular block, Herzschrittmacherther Elektrophysiol, vol.29, pp.166-170, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01855338

T. Kleppisch and M. T. Nelson, Adenosine activates ATP-sensitive potassium channels in arterial myocytes via A2 receptors and cAMP-dependent protein kinase, Proc. Natl. Acad. Sci, vol.92, pp.12441-12445, 1995.

D. J. Cushing, G. L. Brown, M. H. Sabouni, and S. J. Mustafa, Adenosine receptor-mediated coronary artery relaxation and cyclic nucleotide production, Am. J. Physiol, vol.261, pp.343-348, 1991.

C. Ledent, J. M. Vaugeois, S. N. Schiffmann, T. Pedrazzini, M. El-yacoubi et al., Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor, Nature, vol.388, pp.674-678, 1997.
URL : https://hal.archives-ouvertes.fr/hal-02186991

J. C. Shryock, S. Snowdy, P. G. Baraldi, B. Cacciari, G. Spalluto et al., A2A-adenosine receptor reserve for coronary vasodilation, Circulation, vol.98, pp.711-718, 1998.

Z. C. Berwick, G. A. Payne, B. Lynch, G. M. Dick, M. Sturek et al., Contribution of adenosine A(2A) and A(2B) receptors to ischemic coronary dilation: Role of K(V) and K(ATP) channels. Microcirculation, vol.17, pp.600-607, 2010.

M. S. Sanjani, B. Teng, T. Krahn, S. Tilley, C. Ledent et al., Contributions of A2A and A2B adenosine receptors in coronary flow responses in relation to the KATP channel using A2B and A2A/2B double-knockout mice, Am. J. Physiol. Heart Circ. Physiol, vol.301, 2011.

R. R. Neubig, M. Spedding, T. Kenakin, and A. Christopoulos, International Union of Pharmacology Committee on International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology. Receptor Nomenclature and Drug Classification, Pharmacol. Rev, vol.55, pp.597-606, 2003.

L. K. Mcneil and B. D. Evavold, Dissociation of peripheral T cell responses from thymocyte negative selection by weak agonists supports a spare receptor model of T cell activation, Proc. Natl. Acad. Sci, vol.99, pp.4520-4525, 2002.

P. Buchwald, A Receptor Model with Binding Affinity, Activation Efficacy, and Signal Amplification Parameters for Complex Fractional Response Versus Occupancy Data, Front. Pharmacol, vol.10, p.605, 2019.

M. Ickerson, Receptor occupancy and tissue response, Nature, vol.178, pp.697-698, 1956.

T. P. Kenakin, The relative contribution of affinity and efficacy to agonist activity: Organ selectivity of noradrenaline and oxymetazoline with reference to the classification of drug receptors, Br. J. Pharmacol, vol.81, pp.131-141, 1984.

A. J. Clark, Individual Variation in Response to Drugs, Br. Med. J, vol.2, pp.307-310, 1937.

D. Hoyer and H. W. Boddeke, Partial agonists; full agonists, antagonists: Dilemmas of definition, Trends Pharmacol. Sci, vol.14, pp.270-275, 1993.

J. Zsuga, T. Erdei, K. Szabó, N. Lampe, C. Papp et al., Methodical challenges and a possible resolution in the assessment of receptor reserve for adenosine, an agonist with short half-life, vol.22, 2017.

S. P. Moran, H. P. Cho, J. Maksymetz, D. H. Remke, R. M. Hanson et al., PF-06827443 Displays Robust Allosteric Agonist and Positive Allosteric Modulator Activity in High Receptor Reserve and Native Systems, ACS Chem. Neurosci, vol.9, pp.2218-2224, 2018.

L. Jacquin, F. Franceschi, Y. By, J. M. Durand-gorde, J. Condo et al., Search for adenosine A2A spare receptors on peripheral human lymphocytes, FEBS Open Bio, vol.3, pp.1-5, 2012.

F. Franceschi, Y. By, E. Peyrouse, J. Fromonot, V. Gerolami et al., A2A adenosine receptor function in patients with vasovagal syncope, Europace, vol.15, pp.1328-1332, 2013.

J. Ruf, F. Paganelli, L. Bonello, N. Kipson, G. Mottola et al., Spare adenosine A2a receptors are associated with positive exercise stress test in coronary artery disease, Mol. Med, vol.22, pp.530-536, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01465789

F. Paganelli, N. Resseguier, M. Marlinge, M. Laine, F. Malergue et al., Specific pharmacological profile of A(2a) adenosine receptor predicts reduced fractional flow reserve in patients with suspected coronary artery disease, J. Am. Heart Assoc, vol.7, issue.8, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01855307

Y. By, J. M. Durand-gorde, J. Condo, P. J. Lejeune, B. Mallet et al., Production of an agonist-like monoclonal antibody to the human A2A receptor of adenosine for clinical use, Mol. Immunol, vol.46, pp.400-405, 2009.

K. Varani, F. Laghi-pasini, A. Camurri, P. L. Capecchi, M. Maccherini et al., Changes of peripheral A2A adenosine receptors in chronic heart failure and cardiac transplantation, FASEB J, vol.17, pp.280-282, 2003.

V. Gariboldi, D. Vairo, R. Guieu, M. Marlingue, E. Ravis et al., Expressions of adenosine A2A receptors in coronary arteries and peripheral blood mononuclear cells are correlated in coronary artery disease patients, Int. J. Cardiol, vol.230, pp.427-431, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01760745

M. Gaudry, M. Marlinge, P. Deharo, D. Vairo, S. Bottone et al., Pharmacological profile of adenosine A(2A) receptors in patients with lower extremity peripheral artery disease and associated coronary artery disease: A pilot study, Int. J. Cardiol, vol.285, pp.121-127, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02346574

M. Srinivas, J. C. Shryock, D. M. Dennis, S. P. Baker, and L. Belardinelli, Differential A1 adenosine receptor reserve for two actions of adenosine on guinea pig atrial myocytes, Mol. Pharmacol, vol.52, pp.683-691, 1997.

Z. Kiss, K. Pak, J. Zsuga, B. Juhasz, B. Varga et al., The guinea pig atrial A1 adenosine receptor reserve for the direct negative inotropic effect of adenosine, Gen. Physiol. Biophys, vol.32, pp.325-335, 2013.

L. Bruzzese, J. Fromonot, Y. By, J. M. Durand-gorde, J. Condo et al., NF-?B enhances hypoxia-driven T-cell immunosuppression via upregulation of adenosine A(2A) receptors, Cell Signal, vol.26, pp.1060-1067, 2014.

L. Bruzzese, E. Fenouillet, J. Fromonot, J. M. Durand-gorde, J. Condo et al., High homocysteine levels prevent via H2 S the CoCl2-induced alteration of lymphocyte viability, J. Cell Mol. Med, vol.20, pp.1411-1419, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01307326

Z. Yang, Y. J. Day, M. C. Toufektsian, Y. Xu, S. I. Ramos et al., Myocardial infarct-sparing effect of adenosine A2A receptor activation is due to its action on CD4+ T lymphocytes, Circulation, vol.114, pp.2056-2064, 2006.

K. Thygesen, J. S. Alpert, A. S. Jaffe, B. R. Chaitman, J. J. Bax et al., Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction, Fourth Universal Definition of Myocardial Infarction, vol.138, pp.618-651, 2018.

R. Guieu, N. Kipson, J. Ruf, N. Fournier, M. Laine et al., Low basal expression of A2A adenosine receptors and increase in adenosine plasma concentration are associated with positive exercise stress testing, Int. J. Cardiol, vol.180, pp.15-17, 2015.

J. Ruf, D. Vairo, F. Paganelli, and R. Guieu, Extracellular vesicles with ubiquitinated adenosine A2A receptor in plasma of patients with coronary artery disease, J. Cell Mol. Med, vol.23, pp.6805-6811, 2019.

T. Simard, R. Jung, A. Labinaz, M. A. Faraz, F. D. Ramirez et al., Evaluation of plasma adenosine as a marker of cardiovascular risk: Analytical and biological considerations, J. Am. Heart Assoc, vol.8, 2019.

Y. Marunaka, N. Niisato, and H. J. Miyazaki, New concept of spare receptors and effectors, Membr. Biol, vol.203, pp.31-39, 2005.

, Int. J. Mol. Sci, vol.20, p.5964, 2019.

M. D. Silverstein, D. E. Singer, A. G. Mulley, G. E. Thibault, and G. O. Barnett, Patients with syncope admitted to medical intensive care units, JAMA, vol.248, pp.1185-1189, 1982.

R. Guieu, J. C. Deharo, J. Ruf, G. Mottola, N. Kipson et al., Adenosine and clinical forms of neurally-mediated syncope, J. Am. Coll. Cardiol, vol.66, pp.204-205, 2015.

J. C. Deharo, R. Guieu, A. Mechulan, E. Peyrouse, N. Kipson et al., Syncope without prodromes in patients with normal heart and normal electrocardiogram: A distinct entity, J. Am. Coll. Cardiol, vol.62, pp.1075-1080, 2013.

M. Brignole, R. Guieu, M. Tomaino, M. Iori, A. Ungar et al., Mechanism of syncope without prodromes with normal heart and normal electrocardiogram, vol.14, pp.234-239, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01799081

A. Y. Saadjian, V. Gerolami, R. Giorgi, L. Mercier, J. L. Berge-lefranc et al., Head-up tilt induced syncope and adenosine A2A receptor gene polymorphism, Eur. Heart J, vol.30, pp.1510-1515, 2009.